Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 4216 AL 4230

Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson's disease

Sharma SK, Priya S.

Cell Mol Life Sci. 2017 Feb;74(4):617-629. doi: 10.1007/s00018-016-2340-9. Epub 2016 Aug 13.

Antipsychotic drugs in Huntington's disease

Unti E, Mazzucchi S, Palermo G, Bonuccelli U, Ceravolo R.

Expert Rev Neurother. 2017 Mar;17(3):227-237. doi: 10.1080/14737175.2016.1226134. Epub 2016 Aug 23.

Aptamer and its applications in neurodegenerative diseases

Qu J, Yu S, Zheng Y, Zheng Y, Yang H, Zhang J.

Cell Mol Life Sci. 2017 Feb;74(4):683-695. doi: 10.1007/s00018-016-2345-4. Epub 2016 Aug 25.

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models

Naia L, Rosenstock TR, Oliveira AM, Oliveira-Sousa SI, Caldeira GL, Carmo C, Laço MN, Hayden MR, Oliveira CR, Rego AC.

Mol Neurobiol. 2017 Sep;54(7):5385-5399. doi: 10.1007/s12035-016-0048-3. Epub 2016 Sep 2.

Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy

Liu D, Ke Z, Luo J.

Mol Neurobiol. 2017 Sep;54(7):5440-5448. doi: 10.1007/s12035-016-0079-9. Epub 2016 Sep 5.

The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease

Polyzos AA, McMurray CT.

Mech Ageing Dev. 2017 Jan;161(Pt A):181-197. doi: 10.1016/j.mad.2016.09.003. Epub 2016 Sep 12.

Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease

Quintanilla RA, Tapia C, Pérez MJ.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1078-1083. doi: 10.1016/j.bbrc.2016.09.054. Epub 2016 Sep 13.

Energy defects in Huntington's disease: Why "in vivo" evidence matters

Liot G, Valette J, Pépin J, Flament J, Brouillet E.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1084-1095. doi: 10.1016/j.bbrc.2016.09.065. Epub 2016 Sep 14.

Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders

Reis SD, Pinho BR, Oliveira JMA.

Mol Neurobiol. 2017 Oct;54(8):5829-5854. doi: 10.1007/s12035-016-0120-z. Epub 2016 Sep 22.

Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease

Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim KH.

Aging Cell. 2017 Feb;16(1):4-16. doi: 10.1111/acel.12538. Epub 2016 Sep 29.

Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases

Ita K.

J Drug Target. 2017 Jun;25(5):406-419. doi: 10.1080/1061186X.2016.1245310. Epub 2016 Nov 8.

Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders

Bose S, Cho J.

Ageing Res Rev. 2017 May;35:155-175. doi: 10.1016/j.arr.2016.09.004. Epub 2016 Oct 1.

Genetic variation associated with the occurrence and progression of neurological disorders

Little J, Barakat-Haddad C, Martino R, Pringsheim T, Tremlett H, McKay KA, van Lieshout P, Walsh SJ, Gomes J, Krewski D.

Neurotoxicology. 2017 Jul;61:243-264. doi: 10.1016/j.neuro.2016.09.018. Epub 2016 Oct 3.

Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease

Rodríguez-Arribas M, Yakhine-Diop SMS, Pedro JMB, Gómez-Suaga P, Gómez-Sánchez R, Martínez-Chacón G, Fuentes JM, González-Polo RA, Niso-Santano M.

Mol Neurobiol. 2017 Oct;54(8):6287-6303. doi: 10.1007/s12035-016-0140-8. Epub 2016 Oct 6.

Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS)

Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators and Coordinators.

Clin Genet. 2017 Jun;91(6):824-831. doi: 10.1111/cge.12893. Epub 2016 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias